AGP Limited: Earnings Strong, But Seasonal Dip Ahead
AGP Limited (AGP), one of Pakistan’s top pharmaceutical companies, is expected to show strong profits for the second quarter of 2025 (April–June), but a slight...
Top 3 sectors to trade in according to analysts
Wondering where the research houses want their clients to put their money in? If you are a trader and looking to maximize your gains
Why pharma exports could be Pakistan’s next billion-dollar opportunity?
Pakistan’s pharmaceutical industry has been on an upward trajectory thanks to deregulation, margin expansion, and a rising domestic market. But a far less discussed, and...
5 Reasons AGP Limited Could Be Your Next Big Pharma Pick
As Pakistan's pharmaceutical sector evolves rapidly post-deregulation, AGP Limited (AGP) stands out as one of the most attractive investment opportunities. With a strong product mix,...
Pharma Stock Valuations Are at a Discount, Is Now the Time to Buy?
Pakistan’s pharmaceutical sector has quietly morphed into a compelling value play. Despite major regulatory relief, margin expansion, and earnings growth, valuations across the board remain...
Can Pakistan’s local drugmakers outperform multinationals?
Pakistan’s pharmaceutical sector has entered a phase of structural transformation, and one question stands out: Can local drug manufacturers truly outperform multinational companies (MNCs)? Based...
Pharma sector earnings rise, valuations fall: is it a buying opportunity?
The pharmaceutical sector in Pakistan delivered a strong performance in 1QCY25, with listed companies showing robust profitability driven by favorable macro and regulatory developments. Using...